{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04895592",
            "orgStudyIdInfo": {
                "id": "STUDY00001896"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-02761",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "STUDY00001896"
                },
                {
                    "id": "RAD5234-21",
                    "type": "OTHER",
                    "domain": "Emory University Hospital/Winship Cancer Institute"
                },
                {
                    "id": "P30CA138292",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/P30CA138292"
                }
            ],
            "organization": {
                "fullName": "Emory University",
                "class": "OTHER"
            },
            "briefTitle": "Radiosurgery Before Surgery for the Treatment of Brain Metastases",
            "officialTitle": "Preoperative Radiosurgery for Brain Metastases Planned for Surgical Resection: A Two Arm Pilot Study",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "radiosurgery-before-surgery-for-the-treatment-of-brain-metastases"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-07-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-17",
            "studyFirstSubmitQcDate": "2021-05-17",
            "studyFirstPostDateStruct": {
                "date": "2021-05-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-31",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Zachary Buchwald",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Emory University"
            },
            "leadSponsor": {
                "name": "Emory University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This early phase I trial identifies the side effects of stereotactic radiosurgery before surgery in treating patients with cancer that has spread to the brain (brain metastases). Radiation may stimulate an anti-tumor immune response. Giving stereotactic radiosurgery before surgery may reduce the risk of the cancer coming back after surgery.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To determine the safety of pre-operative stereotactic radiosurgery (SRS) followed by surgery for brain metastasis.\n\nSECONDARY OBJECTIVES:\n\nI. To evaluate the immune niche in brain metastasis following SRS in the presence of low or high dose dexamethasone.\n\nII. To evaluate the impact of pre-operative SRS on survival outcomes.\n\nOUTLINE: Patients are assigned to 1 of 2 arms.\n\nARM A: Patients undergo SRS to the brain metastasis for 1-3 fractions over 1-5 days. Patients also receive low dose dexamethasone orally (PO) or intravenously (IV) for 2-21 days until the day of surgical resection. Patients then undergo surgical resection.\n\nARM B: Patients undergo SRS to the brain metastasis for 1-3 fractions over 1-5 days. Patients also receive high dose dexamethasone PO or IV for 2-21 days until the day of surgical resection. Patients then undergo surgical resection.\n\nAfter completion of study intervention, patients are followed up for 120 days, and then every 12 weeks thereafter."
        },
        "conditionsModule": {
            "conditions": [
                "Metastatic Malignant Neoplasm in the Brain",
                "Metastatic Malignant Solid Neoplasm"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm A (SRS, low dose dexamethasone, surgery)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergo SRS to the brain metastasis for 1-3 fractions over 1-5 days. Patients also receive low dose dexamethasone PO or IV for 2-21 days until the day of surgical resection. Patients then undergo surgical resection.",
                    "interventionNames": [
                        "Drug: Dexamethasone",
                        "Procedure: Resection",
                        "Radiation: Stereotactic Radiosurgery"
                    ]
                },
                {
                    "label": "Arm B (SRS, high dose dexamethasone, surgery)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergo SRS to the brain metastasis for 1-3 fractions over 1-5 days. Patients also receive high dose dexamethasone PO or IV for 2-21 days until the day of surgical resection. Patients then undergo surgical resection.",
                    "interventionNames": [
                        "Procedure: Resection",
                        "Radiation: Stereotactic Radiosurgery"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Dexamethasone",
                    "description": "Given PO or IV",
                    "armGroupLabels": [
                        "Arm A (SRS, low dose dexamethasone, surgery)"
                    ],
                    "otherNames": [
                        "Aacidexam",
                        "Adexone",
                        "Aknichthol Dexa",
                        "Alba-Dex",
                        "Alin",
                        "Alin Depot",
                        "Alin Oftalmico",
                        "Amplidermis",
                        "Anemul mono",
                        "Auricularum",
                        "Auxiloson",
                        "Baycadron",
                        "Baycuten",
                        "Baycuten N",
                        "Cortidexason",
                        "Cortisumman",
                        "Decacort",
                        "Decadrol",
                        "Decadron",
                        "Decadron DP",
                        "Decalix",
                        "Decameth",
                        "Decasone R.p.",
                        "Dectancyl",
                        "Dekacort",
                        "Deltafluorene",
                        "Deronil",
                        "Desamethasone",
                        "Desameton",
                        "Dexa-Mamallet",
                        "Dexa-Rhinosan",
                        "Dexa-Scheroson",
                        "Dexa-sine",
                        "Dexacortal",
                        "Dexacortin",
                        "Dexafarma",
                        "Dexafluorene",
                        "Dexalocal",
                        "Dexamecortin",
                        "Dexameth",
                        "Dexamethasone Intensol",
                        "Dexamethasonum",
                        "Dexamonozon",
                        "Dexapos",
                        "Dexinoral",
                        "Dexone",
                        "Dinormon",
                        "Dxevo",
                        "Fluorodelta",
                        "Fortecortin",
                        "Gammacorten",
                        "Hemady",
                        "Hexadecadrol",
                        "Hexadrol",
                        "Lokalison-F",
                        "Loverine",
                        "Methylfluorprednisolone",
                        "Millicorten",
                        "Mymethasone",
                        "Orgadrone",
                        "Spersadex",
                        "TaperDex",
                        "Visumetazone",
                        "ZoDex"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Resection",
                    "description": "Undergo surgical resection",
                    "armGroupLabels": [
                        "Arm A (SRS, low dose dexamethasone, surgery)",
                        "Arm B (SRS, high dose dexamethasone, surgery)"
                    ],
                    "otherNames": [
                        "Surgical Resection"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Stereotactic Radiosurgery",
                    "description": "Undergo SRS",
                    "armGroupLabels": [
                        "Arm A (SRS, low dose dexamethasone, surgery)",
                        "Arm B (SRS, high dose dexamethasone, surgery)"
                    ],
                    "otherNames": [
                        "Stereotactic External Beam Irradiation",
                        "stereotactic external-beam radiation therapy",
                        "Stereotactic Radiation Therapy",
                        "Stereotactic Radiotherapy",
                        "stereotaxic radiation therapy",
                        "stereotaxic radiosurgery"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of adverse events grade 3 or greater",
                    "description": "Evaluated using Common Terminology Criteria for Adverse Events. Tolerability of this regimen will be defined as \\< 33% of patients develop grade \\> 3 at 4 months. Adverse events will be summarized descriptively using frequencies and percentages.",
                    "timeFrame": "At 4 months post-treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Density of immune niche in brain metastases",
                    "description": "Niche density will be assessed by immunofluorescence as described above. It will be summarized descriptively as the percent of tumor occupied by immune niche for each treatment arm, and will be compared between Arms A and B using a two-sample t-test or non-parametric equivalent, such as Mann-Whitney U test.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Time to local recurrence (LR)",
                    "description": "LR will be estimated using the Kaplan-Meier method, and a 95% confidence interval for median LR will be estimated using the Brookmeyer-Crowley approach.",
                    "timeFrame": "From pre-operative stereotactic radiosurgery (SRS) to intracranial progression at the treated site, assessed up to 2 years"
                },
                {
                    "measure": "Time to anywhere brain failure (ABF)",
                    "description": "ABF will be estimated using the Kaplan-Meier method, and a 95% confidence interval for median TBF will be estimated using the Brookmeyer-Crowley approach.",
                    "timeFrame": "From preoperative SRS to intracranial progression at any site within the brain, assessed up to 2 years"
                },
                {
                    "measure": "Overall survival (OS)",
                    "description": "OS will be estimated using the Kaplan-Meier method, and a 95% confidence interval for median OS will be estimated using the Brookmeyer-Crowley approach.",
                    "timeFrame": "From pre-operative SRS initiation to death, assessed up to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\>= 18 years\n* Prior or suspected diagnosis of malignancy\n* Brain metastases visible on contrasted magnetic resonance imaging (MRI) brain\n* Eastern Cooperative Oncology Group (ECOG) performance status =\\< 2 (Karnofsky \\>= 60%)\n* Life expectancy \\> 12 weeks as determined by the investigator\n* Patients must have adequate organ function as determined by Neurosurgery to undergo surgery\n* Willingness and ability of the subject to comply with scheduled visits, study procedures, and study restrictions\n* Evidence of a personally signed informed consent indicating that the subject is aware of the neoplastic nature of the disease and has been informed of the procedures to be followed, the experimental nature of the therapy, alternatives, potential risks and discomforts, potential benefits, and other pertinent aspects of study participation\n* Patient must have a negative pregnancy test, be actively taking oral contraceptives or have undergone a hysterectomy\n\nExclusion Criteria:\n\n* Patients on any immunosuppressive medication other than dexamethasone\n* Patients who are receiving any other investigational agents or an investigational device within 21 days before administration of first dose of study drugs\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements\n* Human immunodeficiency virus (HIV)-positive\n* Pregnant or nursing women are excluded\n* Prior whole brain radiotherapy or SRS to the same site planned for surgery",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Zachary Buchwald, MD, PhD",
                    "role": "CONTACT",
                    "phone": "404-778-1790",
                    "email": "zachary.scott.buchwald@emory.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Zachary Buchwald, MD, PhD",
                    "affiliation": "Emory University Hospital/Winship Cancer Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Emory University Hospital/Winship Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Zachary Buchwald, MD, PhD",
                            "role": "CONTACT",
                            "phone": "404-778-1790",
                            "email": "zachary.scott.buchwald@emory.edu"
                        },
                        {
                            "name": "Zachary S. Buchwald, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001932",
                    "term": "Brain Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000016543",
                    "term": "Central Nervous System Neoplasms"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "asFound": "Brain Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18937",
                    "name": "Central Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003907",
                    "term": "Dexamethasone"
                },
                {
                    "id": "C000018038",
                    "term": "Dexamethasone acetate"
                },
                {
                    "id": "C000089399",
                    "term": "Ichthammol"
                },
                {
                    "id": "C000101468",
                    "term": "BB 1101"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000011480",
                    "term": "Protease Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000003879",
                    "term": "Dermatologic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7102",
                    "name": "Dexamethasone",
                    "asFound": "High",
                    "relevance": "HIGH"
                },
                {
                    "id": "M235549",
                    "name": "Dexamethasone acetate",
                    "asFound": "Occupational",
                    "relevance": "HIGH"
                },
                {
                    "id": "M199152",
                    "name": "BB 1101",
                    "asFound": "Occupational",
                    "relevance": "HIGH"
                },
                {
                    "id": "M256061",
                    "name": "Ichthammol",
                    "asFound": "Country",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M19609",
                    "name": "HIV Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M14343",
                    "name": "Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7074",
                    "name": "Dermatologic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}